Personal information

oncology, genito urinary tumors, renal cell carcinoma, prostate cancer, testis cancer, gastrointestinal tumors
Brazil

Activities

Employment (3)

Hospital Sírio-Libanês: Brasília, Distrito Federal, BR

2023-10-01 to present | Medical Oncologist (Oncology and Hematology Center)
Employment
Source: Self-asserted source
Fernando Monteiro

Hospital Santa Lúcia Sul: Brasilia, Distrito Federal, BR

2016-07-04 to 2023-10-01 (Oncology )
Employment
Source: Self-asserted source
Fernando Monteiro

Hospital Universitário de Brasília: Brasilia, Distrito Federal, BR

2017-09-01 to 2023-01-28 (Oncology)
Employment
Source: Self-asserted source
Fernando Monteiro

Education and qualifications (2)

Pontifícia Universidade Católica do Rio Grande do Sul: Porto Alegre, BR

2020-03-05 to 2024-05-03 | PhD (School of Medicine)
Education
Source: Self-asserted source
Fernando Monteiro

Universidade de Cuiabá: Cuiabá, BR

1998-08-01 to 2004-08-18 | MD (School of Medicine)
Education
Source: Self-asserted source
Fernando Monteiro

Professional activities (4)

American Society of Clinical Oncology: Alexandria, Virginia, US

2024-06-04 to present
Membership
Source: Self-asserted source
Fernando Monteiro

European Society for Medical Oncology: Viganello, TI, CH

2019-03-01 to present
Membership
Source: Self-asserted source
Fernando Monteiro

Latin America Cooperative Oncology Group: Porto Alegre, Rio Grande do Sul, BR

2014-02-01 to present
Membership
Source: Self-asserted source
Fernando Monteiro

Sociedade Brasileira de Oncologia Clínica: Belo Horizonte, MG, BR

2009-01-04 to present
Service
Source: Self-asserted source
Fernando Monteiro

Works (50 of 61)

Items per page:
Page 1 of 2

Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysis

Clinical & Experimental Metastasis
2025-02 | Journal article
Part of ISSN: 0262-0898
Part of ISSN: 1573-7276
Contributors: Alessandro Rizzo; Fernando Sabino Marques Monteiro; Veronica Mollica; Andrey Soares; Oronzo Brunetti; Angela Dalia Ricci; Francesco Massari; Matteo Santoni
Source: Self-asserted source
Fernando Monteiro

A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial

Journal of Clinical Oncology
2024 | Journal article
Contributors: Maluf, Fernando Cotait; Trindade, Karine; Almeida Preto, Daniel D.; Marques Monteiro, Fernando Sabino; Luz, Murilo; Beato, Patricia Milhomem; Bastos, Diogo Assed; Holanda Soares, Joao Paulo; Lopes dos Santos, Victor Marcondes; Werneck De Carvalho, Luis Eduardo et al.
Source: check_circle
Web of Science Researcher Profile Sync

Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysis

Critical Reviews in Oncology/Hematology
2024 | Journal article
Contributors: Monteiro, Fernando Sabino Marques; Soares, Andrey; Mollica, Veronica; Leite, Caio Abner; Carneiro, Andre Paterno Castello Dias; Rizzo, Alessandro; Bourlon, Maria T.; Sasse, Andre Deeke; Santoni, Matteo; Gupta, Shilpa et al.
Source: check_circle
Web of Science Researcher Profile Sync

Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project

Targeted Oncology
2024 | Journal article
Contributors: Rizzo, Alessandro; Monteiro, Fernando Sabino Marques; Urun, Yueksel; Massari, Francesco; Park, Se Hoon; Bourlon, Maria T.; Poprach, Alexandr; Rizzo, Mimma; Takeshita, Hideki; Giannatempo, Patrizia et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study

Scientific Reports
2024 | Journal article
Contributors: Rizzo, Mimma; Soares, Andrey; Grande, Enrique; Bamias, Aristotelis; Kopp, Ray Manneh; Lenci, Edoardo; Buttner, Thomas; Salah, Samer; Grillone, Francesco; de Carvalho, Icaro Thiago et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population

Clinical Genitourinary Cancer
2024 | Journal article
Contributors: Souza, Vinicius Carrera; Monteiro, Fernando Sabino Marques; Maluf, Fernando Cotait; Werutsky, Gustavo; Fabricio, Vanessa de Carvalho; Gidekel, Rosemarie; Gandur-Quiroga, Maria Natalia; Freitas, Marcelo Roberto Pereira; Luz, Murilo; Campos-Gomez, Saul et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de‐differentiation (ARON‐1 study)

International Journal of Cancer
2024-12-01 | Journal article
Part of ISSN: 0020-7136
Part of ISSN: 1097-0215
Contributors: Chiara Ciccarese; Thomas Büttner; Linda Cerbone; Ilaria Zampiva; Fernando Sabino M. Monteiro; Umberto Basso; Martin Pichler; Maria Giuseppa Vitale; Ondrej Fiala; Giandomenico Roviello et al.
Source: Self-asserted source
Fernando Monteiro

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study

Targeted Oncology
2024-11 | Journal article
Part of ISSN: 1776-2596
Part of ISSN: 1776-260X
Contributors: Ondrej Fiala; Francesco Massari; Umberto Basso; Patrizia Giannatempo; Enrique Grande; Sebastiano Buti; Zin W. Myint; Ugo De Giorgi; Renate Pichler; Francesco Grillone et al.
Source: Self-asserted source
Fernando Monteiro

Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)

Targeted Oncology
2024-11 | Journal article
Part of ISSN: 1776-2596
Part of ISSN: 1776-260X
Contributors: Daniele Santini; Haoran Li; Giandomenico Roviello; Se Hoon Park; Enrique Grande; Jakub Kucharz; Umberto Basso; Ondrej Fiala; Fernando Sabino Marques Monteiro; Alexandr Poprach et al.
Source: Self-asserted source
Fernando Monteiro

Surgical Castration as an Alternative to Improve Systemic Treatment for Advanced Prostate Cancer: A Window of Opportunity for Developing Countries

JCO Global Oncology
2024-11 | Journal article
Contributors: Fernando Sabino Marques Monteiro; Andre Deeke Sasse; Denizar Vianna Araujo; Rana R. McKay; Karine Martins da Trindade; Andrey Soares; João Ricardo Alves; Douglas Andreas Valverde; Diogo Assed Bastos; Nicholas D. James et al.
Source: check_circle
Crossref

Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis

Scientific Reports
2024-11-16 | Journal article
Part of ISSN: 2045-2322
Contributors: Elsa Vitale; Alessandro Rizzo; Lorenza Maistrello; Deniz Can Guven; Raffaella Massafra; Veronica Mollica; Fernando Sabino Marques Monteiro; Matteo Santoni; Francesco Massari
Source: Self-asserted source
Fernando Monteiro

Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study

The Oncologist
2024-09-02 | Journal article
Contributors: Fernando Sabino Marques Monteiro; Antonio Machado Alencar Junior; Karine Martins da Trindade; Taiane Francieli Rebelatto; Fernando C Maluf; Antonia A Gazzola; Pablo M Barrios; Joaquim Bellmunt; Rafaela Gomes de Jesus; Gyl Eanes Barros Silva et al.
Source: check_circle
Crossref

Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project

Clinical & Experimental Metastasis
2024-06-08 | Journal article
Part of ISSN: 0262-0898
Part of ISSN: 1573-7276
Contributors: Alessandro Rizzo; Sebastiano Buti; Patrizia Giannatempo; Samer Salah; Javier Molina-Cerrillo; Francesco Massari; Ray Manneh Kopp; Ondřej Fiala; Luca Galli; Zin W. Myint et al.
Source: Self-asserted source
Fernando Monteiro

Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations

Cancer Immunology, Immunotherapy
2024-06-04 | Journal article
Part of ISSN: 1432-0851
Contributors: Lorena Incorvaia; Fernando Sabino Marques Monteiro; Francesco Massari; Se Hoon Park; Giandomenico Roviello; Ondřej Fiala; Zin W. Myint; Jakub Kucharz; Javier Molina-Cerrillo; Daniele Santini et al.
Source: Self-asserted source
Fernando Monteiro

Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).

Targeted oncology
2024-05-05 | Journal article
Contributors: Ondrej Fiala; Buti S; Bamias A; Massari F; Pichler R; Maruzzo M; Grande E; De Giorgi U; Molina-Cerrillo J; Seront E et al.
Source: Self-asserted source
Fernando Monteiro

Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study

Clinical Genitourinary Cancer
2024-04 | Journal article
Contributors: Fernando Sabino Marques Monteiro; Ondřej Fiala; Francesco Massari; Zin W. Myint; Jindrich Kopecky; Jakub Kucharz; Thomas Büttner; Enrique Grande; Maria Teresa Bourlon; Javier Molina-Cerrillo et al.
Source: check_circle
Crossref

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

Cancer immunology, immunotherapy : CII
2024-04-18 | Journal article
Contributors: Massari F; Santoni M; Takeshita H; Okada Y; Tapia JC; Basso U; Maruzzo M; Scagliarini S; Büttner T; Fornarini G et al.
Source: Self-asserted source
Fernando Monteiro

Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update

Journal of Cancer Research and Clinical Oncology
2024-04-09 | Journal article
Contributors: Andrey Soares; Fernando Sabino Marques Monteiro; Karine Martins da Trindade; Adriano Gonçalves e Silva; Ana Paula Garcia Cardoso; André Deeke Sasse; André P. Fay; André Paternò Castello Dias Carneiro; Antonio Machado Alencar Junior; Augusto César de Andrade Mota et al.
Source: check_circle
Crossref

Redefining Rare Genitourinary Cancers: An Initiative Led by the Global Society of Rare Genitourinary Tumors

European Urology
2024-02 | Journal article
Part of ISSN: 0302-2838
Contributors: Tiago Costa de Padua; Fernando Sabino Marques Monteiro; Andrea Necchi; Philippe Spiess
Source: Self-asserted source
Fernando Monteiro

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

Clinical Genitourinary Cancer
2023 | Journal article
Contributors: Santoni, Matteo; Massari, Francesco; Myint, Zin W.; Iacovelli, Roberto; Pichler, Martin; Basso, Umberto; Kopecky, Jindrich; Kucharz, Jakub; Buti, Sebastiano; Salfi, Alessia et al.
Source: check_circle
Web of Science Researcher Profile Sync

GEOGRAPHICAL DIFFERENCES IN THE MANAGEMENT OF METASTATIC DE NOVO RENAL CELL CARCINOMA IN THE ERA OF IMMUNE COMBINATIONS WITH A FOCUS ON THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY

Anticancer Research
2023 | Journal article
Contributors: Mollica, Veronica; Massari, Francesco; Rizzo, Mimma; Morelli, Franco; Grande, Enrique; Iacovelli, Roberto; Molina-Cerrillo, Javier; De Giorgi, Ugo; Fornarini, Giuseppe; Procopio, Giuseppe et al.
Source: check_circle
Web of Science Researcher Profile Sync

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immunecombinations

Annals of Oncology
2023 | Journal article
Contributors: Massari, F.; Grande Pulido, E.; Bamias, A.; Iacovelli, R.; Molina Cerrillo, J.; Procopio, G.; Fiala, O.; Myint, Z. W.; De Giorgi, U. F. F.; Buchler, T. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Geographical differences in the management of metastatic<i> de</i><i> novo</i> renal cell carcinoma in the era of immune-combinations

Minerva Urology and Nephrology
2023 | Journal article
Contributors: Porta, Camillo; Bamias, Aristotelis; Zakopoulou, Roubini; Myint, Zin W.; Cavasin, Nicola; Iacovelli, Roberto; Pichler, Martin; Kopecky, Jindrich; Kucharz, Jakub; Rizzo, Mimma et al.
Source: check_circle
Web of Science Researcher Profile Sync

Impact of COVID-19 pandemic on the treatment of prostate cancer in the Brazilian public health system

Journal of Clinical Oncology
2023 | Journal article
Contributors: Carvalhal, Gustavo; Morbeck, Igor Alexandre Protzner; Herchenhorn, Daniel; Sasse, Andre Deeke; Mckay, Rana R.; Rose, Brent Shane; Maluf, Fernando Cotait; Monteiro, Fernando Sabino Marques; Carrera, Vinicius; Soares, Andrey et al.
Source: check_circle
Web of Science Researcher Profile Sync

Prostate cancer public health system database from Brazil: Racial disparities and heterogeneity of treatment interventions to understand evidence-based practice patterns in a large real-world database

Journal of Clinical Oncology
2023 | Journal article
Contributors: Herchenhorn, Daniel; McKay, Rana R.; Sasse, Andre Deeke; Monteiro, Fernando Sabino Marques; Rose, Brent Shane; Carvalhal, Gustavo; Maluf, Fernando Cotait; Morbeck, Igor Alexandre Protzner; Souza, Vinicius Carrera; Fernandes, Elcio Firminiano et al.
Source: check_circle
Web of Science Researcher Profile Sync

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Cancer Immunology, Immunotherapy
2023 | Journal article
Contributors: Fiala, Ondrej; Buti, Sebastiano; Takeshita, Hideki; Okada, Yohei; Massari, Francesco; Palacios, Georgia Anguera; Dionese, Michele; Scagliarini, Sarah; Buettner, Thomas; Fornarini, Giuseppe et al.
Source: check_circle
Web of Science Researcher Profile Sync

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

European Urology Oncology
2023-07-21 | Journal article
Part of ISSN: 2588-9311
Contributors: Matteo Santoni; Sebastiano Buti; Zin W. Myint; Marco Maruzzo; Roberto Iacovelli; Martin Pichler; Jindrich Kopecky; Jakub Kucharz; Mimma Rizzo; Luca Galli et al.
Source: Self-asserted source
Fernando Monteiro
grade
Preferred source (of 2)‎

The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis

Clinical Genitourinary Cancer
2023-06 | Journal article
Contributors: Fernando Sabino Marques Monteiro; Andrey Soares; Alessandro Rizzo; Matteo Santoni; Veronica Mollica; Enrique Grande; Francesco Massari
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Targeted Oncology
2023-06-27 | Journal article
Part of ISSN: 1776-2596
Part of ISSN: 1776-260X
Contributors: Matteo Santoni; Francesco Massari; Zin W. Myint; Roberto Iacovelli; Martin Pichler; Umberto Basso; Jindrich Kopecky; Jakub Kucharz; Sebastiano Buti; Mimma Rizzo et al.
Source: Self-asserted source
Fernando Monteiro

Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study

Cancer Immunology, Immunotherapy
2023-05-29 | Journal article
Part of ISSN: 0340-7004
Part of ISSN: 1432-0851
Contributors: Matteo Santoni; Zin W. Myint; Thomas Büttner; Hideki Takeshita; Yohei Okada; Elaine T. Lam; Danielle Gilbert; Zsófia Küronya; Deniz Tural; Renate Pichler et al.
Source: Self-asserted source
Fernando Monteiro

Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis.

Cancer immunology, immunotherapy : CII
2023-01-12 | Journal article
Contributors: Santoni M; Rizzo A; Kucharz J; Mollica V; Rosellini M; Marchetti A; Tassinari E; Monteiro FSM; Soares A; Molina-Cerrillo J et al.
Source: Self-asserted source
Fernando Monteiro
grade
Preferred source (of 2)‎

Clinicopathological characterization, FGFR alteration prevalence, and outcomes of locally advanced or metastatic urothelial cancer in Latin America (LACOG 1518)

Journal of Clinical Oncology
2022 | Journal article
Contributors: Souza, Vinicius Carrera; Soares, Andrey; Maluf, Fernando Cotait; Marques Monteiro, Fernando Sabino; Gidekel, Rosemarie; Ardila-Salcedo, Jaime; Gandur-Quiroga, Maria Natalia; Luz, Murilo; Pereira Freitas, Marcelo Roberto; Campos-Gomez, Saul et al.
Source: check_circle
Web of Science Researcher Profile Sync

A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC)

Clinical Genitourinary Cancer
2022-10 | Journal article
Contributors: Fernando Sabino M. Monteiro; Andrey Soares; Vinicius Carrera Souza; Rubens Copia Sperandio; Enrique Grande; Matteo Santoni; Andre Poisl Fay; Andre Deeke Sasse
Source: check_circle
Crossref

“Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil”

Clinical Genitourinary Cancer
2022-09-10 | Journal article
Part of ISSN: 1558-7673
Contributors: Fernando Monteiro
Source: Self-asserted source
Fernando Monteiro

Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study

Cancers
2022-08-26 | Journal article
Contributors: Alessandro Rizzo; Veronica Mollica; Andrea Marchetti; Giacomo Nuvola; Matteo Rosellini; Elisa Tassinari; Javier Molina-Cerrillo; Zin W. Myint; Tomas Buchler; Fernando Sabino Marques Monteiro et al.
Source: check_circle
Crossref

Geographical Differences in Kidney Cancer Outcomes of Patients Treated with Immunotherapy: A Systematic Review

Kidney Cancer
2022-08-04 | Journal article
Part of ISSN: 2468-4562
Part of ISSN: 2468-4570
Contributors: Fernando Monteiro
Source: Self-asserted source
Fernando Monteiro

Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival

Critical Reviews in Oncology/Hematology
2022-06-17 | Journal article
Part of ISSN: 1040-8428
Source: Self-asserted source
Fernando Monteiro

Clear cell adenocarcinoma of the male urethra: clinical case report

Brazilian Journal of Oncology
2021 | Journal article
Part of ISSN: 1806-6054
Source: Self-asserted source
Fernando Monteiro

Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)

JCO Global Oncology
2021-12 | Journal article
Contributors: Fernando Cotait Maluf; Felipe Moraes Toledo Pereira; Pedro Luiz Serrano Uson, Jr; Diogo Assed Bastos; Diogo Augusto Rodrigues da Rosa; Evanius Garcia Wiermann; Fábio A. Schutz; Fábio Roberto Kater; Fernando Nunes Galvão de Oliveira; Fernando Sabino Marques Monteiro et al.
Source: check_circle
Crossref

Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries

JCO Global Oncology
2021-12 | Journal article
Contributors: Fernando S. M. Monteiro; Fabio A. Schutz; Igor A. P. Morbeck; Diogo A. Bastos; Fernando V. de Padua; Leonardo A. G. A. Costa; Manuel C. Maia; Jose A. Rinck Jr; Stenio de Cassio Zequi; Karine M. da Trindade et al.
Source: check_circle
Crossref

PBRM1 Mutations as a Predictive Biomarker for Immunotherapy in Metastatic Renal Cell Carcinoma: A Systematic Review

Kidney Cancer
2021-06-16 | Journal article
Contributors: André Paternò Castello Dias Carneiro; Fernando Sabino Marques Monteiro; Andrey Soares
Source: check_circle
Crossref

The role of 68Gallium-prostate-specific membrane antigen positron emission tomography on staging of high-risk localized prostate cancer: for all high-risk patients or would it be better to select them?

Prostate International
2021-03 | Journal article
Contributors: Fernando Sabino M. Monteiro; Juçara Motta Serafim Eliam; Rafaela Gomes de Jesus; Pedro Cavalcante; Gustavo do Vale Gomes; Bruno Hochhegger; Vinicius K. Gonçalves; Laura Von Wallwitz Freitas; Diego H. Roman; Andre Poisl Fay
Source: check_circle
Crossref

Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities.

International braz j urol : official journal of the Brazilian Society of Urology
2021-03-01 | Journal article
Source: Self-asserted source
Fernando Monteiro

Clinical-pathological characterization and outcomes of metastatic urothelial cancer in Latin America: Retrospective and translational multicenter database (LACOG 1518).

Journal of Clinical Oncology
2021-02 | Journal article
Part of ISSN: 0732-183X
Contributors: Vinicius Carrera Souza; Murilo Luz; Diogo Assed Bastos; Marcelo Roberto Pereira Freitas; Breno Dauster Pereira E Silva; Fernando Sabino M. Monteiro; Roni Fernandes; Manuel Caitano; Karine Trindade; Lucas Nogueira et al.
Source: Self-asserted source
Fernando Monteiro via Crossref Metadata Search

Erdafitinib treatment in Brazilian patients with metastatic urothelial carcinoma (mUC): real-world evidence from an Expanded Access Program

Therapeutic Advances in Medical Oncology
2021-01 | Journal article
Contributors: Fernando Sabino M. Monteiro; Adriano Gonçalves e Silva; Andrea Juliana P. de S. Gomes; Carolina Dutra; Naira Oliveira Ferreira; Rodrigo Coutinho Mariano; Fabio A. Schutz
Source: check_circle
Crossref

Neutropenia prevention in the treatment of post-docetaxel metastatic, castration-resistant prostate cancer with cabazitaxel and prednisone: a multicenter, open-label, single-arm phase IV study

Clinical Genitourinary Cancer
2021-01-06 | Journal article
Part of ISSN: 1558-7673
Source: Self-asserted source
Fernando Monteiro

Mechanical Quantum Sensing in the Search for Dark Matter

ArXiv
2020 | Journal article
Contributors: Carney, Daniel; Krnjaic, Gordan; C. Moore, David; A. Regal, Cindy; Afek, Gadi; Bhave, Sunil; Brubaker, Benjamin; Corbitt, Thomas; Cripe, Jonathan; Crisosto, Nicole et al.
Source: check_circle
Web of Science Researcher Profile Sync

Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic

ONCOLOGY
2020-09-15 | Journal article
Part of ISSN: 0890-9091
Source: Self-asserted source
Fernando Monteiro

First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis

Clinical Genitourinary Cancer
2020-08 | Journal article
Contributors: Fernando Sabino M. Monteiro; Andrey Soares; Márcio Debiasi; Fabio A. Schutz; Fernando Cotait Maluf; Diogo Assed Bastos; Andre Sasse; Carolina G.S. Cauduro; Gabriela Oliveira Mendes; Patricia K. Ziegelmann et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)

Journal of Cancer Research and Clinical Oncology
2020-05-14 | Journal article
Part of ISSN: 0171-5216
Part of ISSN: 1432-1335
Source: Self-asserted source
Fernando Monteiro
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2

Peer review (10 reviews for 4 publications/grants)

Review activity for Einstein. (2)
Review activity for International Braz J Urol. (3)
Review activity for JCO global oncology. (1)
Review activity for Therapeutic advances in urology. (4)